Welcome to our dedicated page for SUNSET CAPITAL ASSETS news (Ticker: SNST), a resource for investors and traders seeking the latest updates and insights on SUNSET CAPITAL ASSETS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SUNSET CAPITAL ASSETS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SUNSET CAPITAL ASSETS's position in the market.
Aphex BioCleanse Systems (OTCPK: SNST), a provider of eco-friendly cleaning solutions, has received a new patent (US 11,112,397) from the U.S. Patent and Trademark Office for its Open-Cell Foam Biological Indicator, which enhances bacteria detection and removal from water and air. This patent strengthens the company's growing intellectual property portfolio, covering various foam compositions and methods. The company's BioFoam technology significantly increases disinfectant efficacy, thereby reducing pathogen risk. This development is anticipated to create new operational and revenue opportunities.
Aphex BioCleanse Systems, Inc. (OTCPK: SNST) showcased its sustainable cleaning products at ASD Market Week in Las Vegas. The company's Chief Sustainability Officer, Scott Smith, delivered a keynote on eco-friendly cleaning solutions and highlighted the recently acquired BioFoam™ product line. This patented technology enhances cleaning without harming the environment. Aphex reported strong booth traffic and interest from B2B customers, indicating potential growth from increased partnerships and direct orders. The innovative cleaning technology aims to address waste in the cleaning sector.
Aphex BioCleanse Systems, Inc. (OTCPK: SNST) announced the assignment of two CAS Registry Numbers® for its proprietary sanitization product, Hy-IQ® Water, which recently received trademarks in the EU and UK. This advancement emphasizes the company's commitment to obtaining FDA, USDA, and EPA approvals, moving one step closer to becoming the first FDA-approved hand sanitizer. Hy-IQ® Water is highlighted for its effectiveness against various pathogens, including human coronavirus and MRSA, and is non-toxic and alcohol-free.
Aphex BioCleanse Systems (OTCPK: SNST) announced a partnership with Bifulco Consulting Group to enhance its distribution network. This collaboration aims to leverage Bifulco's extensive B2B and B2C connections, including Fortune 500 companies, for improved marketing and sales of Aphex's non-toxic sanitization products. Aphex's proprietary Hy-IQ® Water technology is noted for its efficacy in killing pathogens without harmful chemicals. The partnership is expected to significantly extend Aphex's market reach in various sectors, including homes, offices, and healthcare.
Aphex BioCleanse Systems, Inc. (SNST) announced a substantial purchase order from Infinity Manufacturing for 13,750 gallons of its DermAphex® alcohol-free hand sanitizer. This order highlights the versatility of Aphex's sanitization solutions, which utilize the company's unique Hy-IQ® Water technology, proven effective against various pathogens including human coronavirus and MRSA. The collaboration aims to address the high demand for safe, cost-effective sanitizing options across multiple industries. CEO David J. Weaver emphasized the potential for expanding product distribution through Infinity's channels.
On April 27, 2021, Aphex BioCleanse Systems (OTCPK: SNST) announced the promotion of Board Director Anthony Fedor to Chairman of the Board. Fedor has over 55 years of manufacturing experience, having held significant positions at Eastman Kodak and successfully running Rochester Gear, Inc.. Aphex specializes in non-toxic sanitization products, particularly its proprietary Hy-IQ® Water, which aims to provide a safer alternative to alcohol-based sanitizers. The company seeks FDA approval for its innovative cleaning technology that has shown effectiveness against pathogens.
Aphex BioCleanse Systems (OTCPK: SNST) announced the appointment of Mark Timm as Chief Marketing Officer and Board Member. Timm's extensive experience in retail, manufacturing, and digital marketing brings significant growth potential. The company specializes in non-toxic, hydrogen-based sanitization technology, Hy-IQ® Water, which has shown effectiveness in killing pathogens. Aphex aims to secure FDA approval for its hand sanitizer products, positioning itself to disrupt the sanitization market.
Aphex BioCleanse Systems (OTCPK: SNST) will host a webcast on April 1, 2021, at 5:30 p.m. EDT to engage with the investment community. CEO David Weaver and EVP David Olund will address shareholder questions during the session. Interested participants can register via the provided link and send inquiries ahead of time. Aphex is known for its Hy-IQ® Water technology, a non-toxic sanitizing solution. The company aims to be the first FDA-approved hand sanitizer using this innovative method. Archived access will be available post-webcast.
FAQ
What is the market cap of SUNSET CAPITAL ASSETS (SNST)?
